N/A N=321 A Comparison of Continuation Rates for Three Hormonal Contraceptive Methods
Contraception
Primary: Continuation Rates — 82; 78; 83 participants
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=1,919 Evaluation of Participant Responses to Educational Counseling About Different Combined Hormonal Contraceptive Choices (P06557)
Contraception
Primary: Number of Participants Choosing Each Hormonal Contraceptive Method Before and After Counseling — 1207; 1199; 60; 131 Participants — p=0.705
N/A N=246 Contraceptive Counseling Following an Abortion
Post Abortion Care
Primary: Contraceptive Acceptability and Use of Contraceptives During the 6-month Follow-up — 121; 86 participants
N/A N=138 Improving Effective Contraceptive Use Among Opioid-maintained Women: Stage II
Contraceptive Usage · Opioid Dependence
Primary: Percentage of Participants With Verified Prescription Contraceptive Use at the 6-month Assessment — 5; 14; 23 Participants — p=<.001
N/A N=786 Patient-Centered Support for Contraceptive Decision-Making
Contraception · Contraceptive Behavior
Primary: Contraceptive Continuation — 201; 174; 154; 118 Participants — p=0.46
N/A N=253 Computerized Contraceptive Decision Aid
Contraception · Decision Making · Satisfaction
Primary: Decisional Conflict Scale Score — 15; 10; 0; 0 score on a scale
Phase 4 N=600 Premature Discontinuation of Contraceptive Implants
Contraception Behavior
Primary: Number of Participants With Implant Continuation — 219; 225 Participants
N/A N=207 RCT: Can a Single Counseling Phone Call Improve Contraception After an Abortion?
Contraception
Primary: Number of Participants Using an Effective Contraceptive Method 6 Weeks After Abortion — 55; 55 Participants
N/A N=197 Breastfeeding and Oral Contraceptives: a Randomized, Controlled Trial
Breast Feeding · Contraception
Primary: Number of Participants Who Continued to Breastfeed at 6 Months — 15; 14; 8; 9 participants
N/A N=1,008 Innovative Model of Patient-Centered ConTraception
Contraception · Unintended Pregnancy
Primary: Unintended Pregnancy — 46; 25 Participants
Early Phase 1 N=40 Ovarian Function With ENG Implant and UPA Use
Contraception
Primary: Number of Participants With Ovulation With Implant-alone — 7; 0 Participants
N/A N=168 Initiating Contraception After Emergency Contraception From Pharmacy
Contraceptive Use After Emergency Contraception
Primary: Self-reported Uptake of Effective Ongoing Contraception (Not Condoms) — 5; 13; 22; 0 participants — p=<0.001
N/A N=64 Oral Contraceptive Hormone-free Interval Pituitary/ Ovarian Activity
Hypothalamic-pituitary-ovarian Axis, Gonadotropins, Ethinyl Estradiol, Contraceptive Efficacy
Primary: Follicle-stimulating Hormone — 5.01; 5.86; 6.38 milli international units per milliliter — p=0.88
Phase 3 N=567 LCS12 vs Combined Oral Contraceptive (COC) User Satisfaction Study
Contraception
Primary: Overall Satisfaction Rate at 18 Months (Last Observation Carried Forward, LOCF) — 82.1; 81.9 Percentage of participants
N/A N=20 Patient Centered Postpartum Contraception App
Contraceptive Usage
Primary: Feasibility of Application — 4.47; 4.52; 4.16; 4.26 units on a scale
Phase 3 N=1,384 AMP002 Phase III Contraceptive Study
Contraception
Primary: Number of Subjects With Pregnancy Outcomes to Measure Contraceptive Efficacy — 100 Participants
Phase 3 N=343 Emergency Contraception Actual Use Study
Emergency Contraception
Primary: Percentage of Participants Who Appropriately Self-selected DR-104 (Plan B® 1.5) When Dispensed Under Simulated Over-the-counter (OTC) Conditions — 90.1 percentage of…
Phase 4 N=36 Impact of Combined Hormonal Contraceptives on UPA
Contraception
Primary: Number of Participants With Follicle Rupture — 1; 9 Participants
Phase 3 N=1,565 Study of the Safety and Contraceptive Efficacy of C31G Compared to Conceptrol®
Pregnancy
Primary: The Cumulative Probability of Typical-use 6 Month (183 Days) Pregnancy. — 0.12; 0.12 6 month probability of pregnancy
Phase 4 N=894 Long-Acting Reversible Contraception
Contraception
Primary: Contraceptive Method Discontinuation — 300; 62; 142 Participants
Phase 4 N=69 Early Versus Standard Postpartum Insertion of the Etonogestrel Contraceptive Implant
Complications; Contraceptive · Female Lactation
Primary: Time to Lactogenesis Stage II — 64.3; 65.2 hours — p=<0.05
N/A N=40 Comparison of Serum Contraceptive Hormone Levels Between Normal Weight and Obese Users of the NuvaRing®
Pharmacokinetics
Primary: Mean Serum Concentrations of Etonogestrel and Ethinyl Estradiol — 1275; 1240; 21.9; 14.8 ng/L
N/A N=700 Ulipristal Emergency Contraception Used Before or After Ovulation
Contraception
Primary: Percentage of Pregnancies Prevented (PPP) — 77.5; 36.9 percentage of pregnancies prevented — p=<0.0001
Phase 4 N=252 Study of the Use of a Contraceptive Vaginal Ring (NuvaRing) in Normal Daily Practice in Indian Women (P07733)
Contraception
Primary: Number of Participants With Regular Menstrual Cycles — 192; 9; 3; 199 Participants
Phase 3 N=1,683 Study of Safety and Efficacy of an Oral Contraceptive
Contraception
Primary: Pregnancy Rate (Expressed as Pearl Index) in Women Aged 18 to 35, MITT Population, — 2.554 Pregnancy Rate
N/A N=57 Copper T380 IUD Versus Oral Levonorgestrel for Emergency Contraception vs. Plan B for Emergency Contraception
Pregnancy
Primary: Use of an Effective Method of Contraception at 6 Months After Requesting Emergency Contraception — 9; 13 participants
N/A N=100 The Impact of Contraception on Postpartum Weight Loss
Weight
Primary: Weight — 3.2; 6.8; 7.0 percent weight lost — p=<0.05
Phase 3 N=450 Contraceptive Effectiveness and Safety of the SILCS Diaphragm
Contraception
Primary: Percent Probability of Pregnancy Among Users of the SILCS Diaphragm Used With Contraceptive Gel Over 6 Months of Typical Use — 12.5; 9.6 percent probability
N/A N=293 Same Day Oral EC and Implant Initiation
Contraception
Primary: Pregnancy Rate at One-month — 1.96 percentage of participants
N/A N=990 Testing the Impact of Two Posters on Contraceptive Knowledge, Contraceptive Preferences, and Perceived Pregnancy Risk
Contraception · Knowledge, Attitudes, Practice
Primary: Change in Contraceptive Knowledge Assessment (CKA) Score — 0.90; 1.6 scores on a scale — p=<0.0001